Appropriateness of Spironolactone Prescribing in Heart Failure Patients: A Population-Based Study
Authors:
- Dennis T. KoDKDennis T. Ko
- David N. JuurlinkDJDavid N. Juurlink
- Muhammad M. MamdaniMMMuhammad M. Mamdani
- John J. YouJYJohn J. You
- Julie T. WangJWJulie T. Wang
- Linda R. DonovanLDLinda R. Donovan
- Jack V. TuJTJack V. Tu
- 1 April 2006
- journal article
- research article
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 12 (3) , 205-210
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation StudyNew England Journal of Medicine, 2004
- Serum Aldosterone and the Incidence of Hypertension in Nonhypertensive PersonsNew England Journal of Medicine, 2004
- Predicting Mortality Among Patients Hospitalized for Heart FailureJAMA, 2003
- Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 casesBMJ, 2003
- Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 2003
- Long-Term Trends in the Incidence of and Survival with Heart FailureNew England Journal of Medicine, 2002
- ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summaryJACC, 2001
- Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 casesThe American Journal of Medicine, 2001
- Early uptake of research findings after fast-track publicationThe Lancet, 2000
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999